Solid Biosciences received clearance from the Food and Drug Administration for an investigational new drug application, the company said Tuesday.
The SF-86 requires the applicant to disclose a wide range of sensitive data, including criminal history, financial status, ...
clearance of its Investigational New Drug (IND) application for STAR-0310, a monoclonal antibody OX40 antagonist, the company is developing as a potential treatment for atopic dermatitis (AD ...